❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ News archive ❭

Institute seminar February 27th Guro Elisabeth Lind

The Institute Seminar on Wednesday February 27th will ble held by Guro Elisabeth Lind from Section of Cancer Prevention.
Title of her talk: ”Epigenetic biomarkers in cancer – their functional and clinical importance”.

Time and place: 12 - 13 in the Auditorium, New Research Building, Montebello

Links:

Guro E. Lind's group: Epigenetics

Guro E. Lind's publications

Section of Cancer Prevention

Insitute seminars, spring season 2013

 
Scroll to top

Home Cancer Medicine Institute for Cancer Research

  • Dept. of Cancer Genetics
  • Dept. of Cancer Immunology
  • Dept. of Molecular Cell Biology
  • Dept. of Molecular Oncology
  • Dept. of Radiation Biology
  • Dept. of Tumor Biology
  • Dept. of Core Facilities
  • Institute employees
  • Dept./group overview
  • Publications
  • Institute administration
  • Annual reports
  • Institute seminars
  • Vacant positions
  • News archive
  • Scientific Advisory Board
  • ehåndbok/HES procedures

Recent publications

From major journals, first or last author from the Institute for Cancer Research

Landsverk HB, Sandquist LE, Bay LTE, Hauge S, van Bijsterveldt L, Lindbergsengen L, Lund-Andersen C, Kanduri C, Lyng H, Fjeldbo CS, Hompland T, Humphrey TC, Syljuåsen RG (2026)
Transcription termination counteracts DNA damage after WEE1 inhibition
Nucleic Acids Res, 54 (3)
DOI 10.1093/nar/gkaf1487, PubMed 41569153

Solli E, Bevilacqua A, Wenes M, Migliorini D, van der Veen L, Skånland SS, Di Conza G, Taskén K (2026)
The PI3Kδ inhibitor roginolisib (IOA-244) preserves T-cell function and activity
Mol Oncol (in press)
DOI 10.1002/1878-0261.70203, PubMed 41568714

Teles-Reis J, Rusten TE (2026)
Tumour-host interactions in Drosophila: mechanisms in the tumour micro- and macroenvironment
Mol Oncol (in press)
DOI 10.1002/1878-0261.70207, PubMed 41546533

More selected publications

Most recent publications

Solli E, Bevilacqua A, Wenes M, Migliorini D, van der Veen L, Skånland SS, Di Conza G, Taskén K (2026)
The PI3Kδ inhibitor roginolisib (IOA-244) preserves T-cell function and activity
Mol Oncol (in press)
DOI 10.1002/1878-0261.70203, PubMed 41568714

Landsverk HB, Sandquist LE, Bay LTE, Hauge S, van Bijsterveldt L, Lindbergsengen L, Lund-Andersen C, Kanduri C, Lyng H, Fjeldbo CS, Hompland T, Humphrey TC, Syljuåsen RG (2026)
Transcription termination counteracts DNA damage after WEE1 inhibition
Nucleic Acids Res, 54 (3)
DOI 10.1093/nar/gkaf1487, PubMed 41569153

Teles-Reis J, Rusten TE (2026)
Tumour-host interactions in Drosophila: mechanisms in the tumour micro- and macroenvironment
Mol Oncol (in press)
DOI 10.1002/1878-0261.70207, PubMed 41546533

More publications

Annual summary of publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)